Heart failure and Ca++ activation of the cardiac contractile system: hereditary cardiomyopathy in hamsters (BIO 14.6), isoprenaline overload and the effect of APP 201-533
- 23 Downloads
Within the same species (RB hamsters, BIO 14.6 hamsters or rabbits), the Ca sensitivity, measured as pCa for half maximal Ca activation, was invariably higher in left than in right ventricular skinned fibres.
During the development of hereditary cardiomyopathy (BIO 14.6), maximum Ca-activated tension, measured per unit cross-sectional area, was reduced in an age-dependent manner, without any significant reduction in Ca sensitivity. This effect appeared to be more pronounced in left than in right ventricles.
In skinned fibres from right or left ventricular papillary muscles from in vitro isoprenaline pretreated rabbit hearts, no significant alteration in the maximum Ca-activated tension (per unit area) was observed in comparison to non-pretreated control hearts, whereas the Ca sensitivity was reduced. Treatment of control or failing heart skinned fibres with cAMP showed no additivity to the Ca desensitization induced by isoprenaline pretreatment.
Skinned fibres from isoprenaline pretreated left ventricular rabbit hearts showed a higher susceptibility to the Ca sensitizing effect of APP 201-533 than fibres from unpretreated control hearts.
Mild isoprenaline overload and hereditary cardiomyopathy both are forms of heart failure which are presumably not associated with a lack of activator Ca. It is concluded that cardiotonic agents increasing the cardiac myofibrillar sensitivity to Ca ions would be beneficial in both cases, representing a phenomenologically causative treatment in hearts failing due to isoprenaline pretreatment. A main advantage over “classical” cardiotonic agents like cardiac glycosides, beta adrenergic stimulants or phosphodiesterase inhibitors would be the absence of the risk of drug-induced Ca overload.
Key wordsheart failure hereditarycardiomyopathy isoprenaline positiveinotropic effect myocardial skinnedfibres Ca−+ sensitivity APP 201-533
Unable to display preview. Download preview PDF.
- 2.Bhan A, Malhotra A, Sonnenblick EH, Scheuer J (1975) Decreased actomyosin ATPase activity in hamster myopathy. Circulation 51–52 Suppl:II-161Google Scholar
- 4.Cole HA, Frearson N, Moir AJG, Perry SV, Solaro RJ (1978) Phosphorylation of cardiac myofibrillar proteins. In: Kobayashi T et al (eds) Recent Advances in Studies on Cardiac Structure and Metabolism, Vol 11, Baltimore, University Park Press, pp 111–120Google Scholar
- 5.Dhalla NS, Sulakhe PF, Fedelsova M, Yates JC (1974) Molecular abnormalities in cardiomhopathy. Adv Cardiol 13:283–300Google Scholar
- 6.England PJ, Ray KP, Hibberd MG, Jeacocke SA, Murray KJ, Hollinworth DN (1979) The control of cardiac contractility by protein phosphorylation. In: Dumont J, Nunez J (eds) Hormones and Cell Regulation, Vol 3, pp 99–114. Elsevier/North Holland Biomedical PressGoogle Scholar
- 7.Fabiato A (1981) Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle. J Gen Physiol 78:457–497PubMedGoogle Scholar
- 10.Herzig JW, Feile K, Rüegg JC (1981) Activating effects of AR-L 115 BS on the Ca-sensitive force, stiffness and unloaded shortening velocity (Vmax) in isolated contractile structures from mammalian heart muscle. Arzneim Forsch/Drug Res 31:188–191Google Scholar
- 11.Herzig JW, Köhler G, Pfitzer G, Rüegg JC, Wölffle G (1981) Cyclic AMP inhibits contractility of detergent treated glycerol extracted cardiac muscle. Pflügers Arch Eur J Physiol 391:208–212Google Scholar
- 12.Herzig JW, Bormann G, Botelho L, Erdmann E, Salzmann R, Solaro RJ (1983) APP 201-533, a novel cardiotonic agent: Increase in Ca-sensitivity and economization of the myocardial contractile process. J Mol Cell Cardiol 15 Suppl I:244Google Scholar
- 13.Herzig JW, Quast U (1984) Increase in Ca-sensitivity of myocardial contractile structures by DPI 201-106. J Mol Cell Cardiol 16 Suppl 3:6Google Scholar
- 14.Herzig JW, Quast U (in press) Ca-sensitization of cardiac contractile proteins: Direct interaction with troponin C? In: Taira N et al (eds) Proceedings of the First International Conference on Search for New Positive Inotropic Agents at Sendai 1985Google Scholar
- 15.Hibberd MG, Jewell BR (1982) Calcium- and length-dependent force production in rat ventricular muscle. J Physiol (Lond) 329:527–540Google Scholar
- 17.Holroyde MJ, Howe E, Solaro RJ (1979) Modification of calcium requirements for activation of cardiac myofibrillar ATPase by cyclic AMP dependent phosphorylation. Biochim Biophys Acta 586:63–69Google Scholar
- 28.Perrin DD, Sayce IG (1967) Computer calculation of equilibrium concentrations in mixtures of metal ions and complexing species. Talanta 14:833–842Google Scholar
- 29.Quast U (1985) Effects of APP 201-533, amrinone and milrinone on the actomyosin ATPases from heart and skeletal muscle. Naunyn-Schmiedeberg's Arch Pharmacol 329 Suppl: R51Google Scholar
- 30.Resink TJ, Gevers W (1981) Altered adenosine triphosphatase activity of natural actomyosin from rat hearts perfused with isoprenaline and ouabain. Cell Calcium 2:105–123Google Scholar
- 33.Schaub MC, Tuchschmid CR, Srihari T, Hirzel HO (1984) Myosin isoenzymes in human hypertrophic hearts. Shift in atrial myosin heavy chains and in ventricular light chains. Eur Heart J 5 Suppl F:85–93Google Scholar
- 34.Scholtysik G, Salzmann R, Berthold R, Herzig JW, Quast U, Markstein R (1985) DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn-Schmiedeberg's Arch Pharmacol 329:316–325Google Scholar
- 35.Solaro RJ, Moir AJG, Perry SV (1976) Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused heart. Nature 246:615–617Google Scholar
- 36.Solaro RJ, Holroyde MJ, Herzig JW, Peterson J (1980) Cardiac relaxation and myofibrillar interactions with phosphate and vanadate. Eur Heart J 1 Suppl A:21–27Google Scholar
- 38.Strobeck JE, Factor SM, Bhan A, Sole M, Liew CC, Fein F, Sonnenblick EM (1979) Hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical and structural features. Ann NY Acad Sci 31:58–88Google Scholar
- 42.Wada A, Yoneda H, Shibata N, Inui Y, Onishi S (1975) Morphological and biochemical studies on the heart of the cardiomyopathic Syrian hamster. Rec Adv. Stud Card Struct Metab 6:275–282Google Scholar